1998760-00-1
Chemical Structure
Zevaquenabant
Synonym(s): (S)-MRI-1867
- CAS No.: 1998760-00-1
- Formula:C25H21ClF3N5O2S
- Molecular Weight:547.98
IUPAC Name: (S,Z)-N-((Z)-1-aminoethylidene)-3-(4-chlorophenyl)-4-phenyl-N'-((4-(trifluoromethyl)phenyl)sulfonyl)-4,5-dihydro-1H-pyrazole-1-carboximidamide
InChIKey: NLXIJZHFEOSWPU-JOCHJYFZSA-N
SMILES: O=S(/N=C(N1N=C(C2=CC=C(Cl)C=C2)[C@@H](C3=CC=CC=C3)C1)/N=C(N)/C)(C4=CC=C(C(F)(F)F)C=C4)=O
Biological Activity: Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual cannabinoid CB1 receptor and inducible NOS antagonist. Zevaquenabant ameliorates obesity-induced chronic kidney disease (CKD)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zevaquenabant | 99.64% | Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual cannabinoid CB1 receptor and inducible NOS antagonist. Zevaquenabant ameliorates obesity-induced chronic kidney disease (CKD). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
